: The TYK2:p.Pro1104Ala (rs34536443) hypomorph variant has been associated with protection against numerous autoimmune disorders. Thus, its mechanism of action becomes of great interest. Here, consistent with the participation of activated immune cells in autoimmunity, we show that the variant regulates the levels of immune cells at a human, general population level and is associated particularly with higher levels of T and B lymphocytes, especially the naïve (non-activated) compartment. Also, consistent with a protective function in autoimmunity, the level of regulatory CD4+ T cells was increased. Thus, this variant decreases immune activation thereby protecting from autoimmunity. Our work links the cellular mechanism regulated by the TYK2:p.Pro1104Ala variant to autoimmunity protection and supports TYK2 as a therapeutic target in autoimmunity.
TYK2:p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels / Steri, Maristella; Orrù, Valeria; Sidore, Carlo; Mulas, Antonella; Pitzalis, Maristella; Busonero, Fabio; Maschio, Andrea; Serra, Valentina; Dei, Mariano; Lai, Sandra; Virdis, Francesca; Lobina, Monia; Loizedda, Annalisa; Marongiu, Michele; Masala, Marco; Floris, Matteo; Curreli, Nicolò; Balaci, Lenuta; Loi, Francesco; Pilia, Maria Grazia; Delitala, Alessandro; Fiorillo, Edoardo; Schlessinger, David; Zoledziewska, Magdalena. - In: IMMUNOLOGY. - ISSN 0019-2805. - (2025). [10.1111/imm.13902]
TYK2:p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels
Orrù, Valeria;Sidore, Carlo;Pitzalis, Maristella;Floris, Matteo;Delitala, Alessandro;Zoledziewska, Magdalena
2025-01-01
Abstract
: The TYK2:p.Pro1104Ala (rs34536443) hypomorph variant has been associated with protection against numerous autoimmune disorders. Thus, its mechanism of action becomes of great interest. Here, consistent with the participation of activated immune cells in autoimmunity, we show that the variant regulates the levels of immune cells at a human, general population level and is associated particularly with higher levels of T and B lymphocytes, especially the naïve (non-activated) compartment. Also, consistent with a protective function in autoimmunity, the level of regulatory CD4+ T cells was increased. Thus, this variant decreases immune activation thereby protecting from autoimmunity. Our work links the cellular mechanism regulated by the TYK2:p.Pro1104Ala variant to autoimmunity protection and supports TYK2 as a therapeutic target in autoimmunity.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.